Screener
West Pharmaceutical Services WST Q2 2025 earnings
Reported July 24, 2025 · Before market open
Revenue$766.2MBeat by $40.1M
EPS$1.84Beat by $0.33
Revenue estimate$726.1M
EPS estimate$1.51
Next report
Oct 22, 2026 (in 2 months)Revenue estimate$825.9M
EPS estimate$2.18
Segments
By segment
Versus estimates
Revenue
Diluted EPS
FAQ
- When did West Pharmaceutical Services report Q2 2025 earnings?
- West Pharmaceutical Services (WST) reported Q2 2025 earnings on July 24, 2025 before market open.
- What were West Pharmaceutical Services's Q2 2025 revenue and EPS?
- West Pharmaceutical Services reported revenue of $766.2M and eps of $1.84 for Q2 2025.
- Did West Pharmaceutical Services beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $726.1M by $40.1M. EPS beat the consensus estimate of $1.51 by $0.33.
- How did West Pharmaceutical Services's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 9.1% from $702.0M a year earlier and eps grew 21.1% from $1.52.
- Where can I find West Pharmaceutical Services's Q2 2025 SEC filings?
- You can read the 8-K earnings release (0000105770-25-000058) and the 10-Q periodic report (0000105770-25-000065) directly on SEC EDGAR. The filing index links above go to sec.gov.
